Markets:

Overview

News

Currencies

International

Treasuries

Alcon Inc. Ordinary Shares (NY:ALC)

80.65 -0.37 (-0.46%)

Streaming Delayed Price Updated: 3:40 PM EST, Jan 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Alcon Inc. Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 Next >

Alcon May Struggle To Meet 2023 Margin Targets With This Latest Acquisition, Says This Analyst ↗

August 23, 2022

Via Benzinga

Stocks Cut Lower As Dow Sheds Another Triple Digits ↗

August 23, 2022

Though most sectors are suffering today, especially real estate and healthcare, energy stocks are on the rise as oil prices make a big resurgence.

Via Talk Markets

Why Windtree Therapeutics Is Trading Higher By Over 60%, Here Are 61 Stocks Moving In Tuesday's Mid-Day Session ↗

August 23, 2022

Gainers

Via Benzinga

Aerie Pharmaceuticals (NASDAQ: AERI) Enters into Agreement to be Acquired by Alcon (NYSE: ALC) for $770 Million

August 23, 2022

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) is engaged within the research, development and commercialization of ophthalmic therapies for the treatment of

Via Spotlight Growth

Why Is Aerie Pharmaceuticals (AERI) Stock Up 35% Today? ↗

August 23, 2022

Aerie Pharmaceuticals (AERI) stock is rising higher on Tuesday following news of a $770 million acquisition deal with Alcon (ALC).

Via InvestorPlace

Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million ↗

August 23, 2022

The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie.

Via Investor's Business Daily

Why Zoom Video Is Trading Lower By 11%; Here Are 28 Stocks Moving Premarket ↗

August 23, 2022

Gainers Quotient Limited (NASDAQ: QTNT) shares rose 58.2% to $0.3070 in pre-market trading. Quotient recently reported a wider Q1 loss.

Via Benzinga

Palo Alto Networks, Aerie Pharmaceuticals And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 23, 2022

Via Benzinga

Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio ↗

August 23, 2022

Via Benzinga

U.S. Stock Futures Edge Higher Following Monday's Sell-Off, Crude Oil Rises ↗

August 23, 2022

Pre-open movers

Via Benzinga

Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio

August 22, 2022

From Alcon Inc. Investors

Via Business Wire

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session ↗

August 10, 2022

Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.

Via Benzinga

WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday ↗

August 10, 2022

OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.

Via Benzinga

Why Is CarLotz Higher By More Than 30%: Here Are 28 Stocks Moving Premarket ↗

August 10, 2022

Gainers ObsEva SA (NASDAQ: OBSV) shares rose 33.8% to $0.4080 in pre-market trading. ObsEva recently announced a $31 million debt retirement and $11 million debt refinancing.

Via Benzinga

Alcon: Q2 Earnings Insights ↗

August 09, 2022

Alcon (NYSE:ALC) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Alcon beat estimated earnings by 28.57%,...

Via Benzinga

Alcon Reports Second Quarter 2022 Results

August 09, 2022

From Alcon Inc. Investors

Via Business Wire

Earnings Preview For Alcon ↗

August 08, 2022

Alcon (NYSE:ALC) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Alcon will report an...

Via Benzinga

Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday

June 06, 2022

From Alcon Inc. Corporate

Via Business Wire

Retina Technologies Reports Working With Major Health Systems To Boost Access to Eye Testing ↗

June 01, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. While established manufacturers of...

Via Benzinga

Alcon Prices EUR 500.0 Million Senior Notes Offering

May 24, 2022

From Alcon Inc. Investors

Via Business Wire

This Biopharma Stock Surges After Offloading Its Ophthalmic Eye Drop Portfolio ↗

May 23, 2022

Via Benzinga

Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio

May 23, 2022

From Alcon Inc. Investors

Via Business Wire

Alcon: Q1 Earnings Insights ↗

May 10, 2022

Alcon (NYSE:ALC) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Alcon beat estimated earnings by 38.78%,...

Via Benzinga

Alcon Reports First Quarter 2022 Results

May 10, 2022

From Alcon Inc. Investors

Via Business Wire

Alcon Announces Results of 2022 Annual General Meeting

April 27, 2022

From Alcon Inc. Investors

Via Business Wire

Alcon’s SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries

April 23, 2022

From Alcon Inc. Corporate

Via Business Wire

Alcon to Deliver Robust Scientific Program at ASCRS 2022

April 20, 2022

From Alcon Inc. Investors

Via Business Wire

Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count

April 08, 2022

From Alcon Inc. Corporate

Via Business Wire

Needham Initiates Alcon Citing 'Visible Path to Sustainable Double-Digit EPS Growth' ↗

April 08, 2022

Needham is initiating coverage on Alcon AG (NYSE: ALC) with a Buy rating and a $95 price target. The analysts believe Alcon has visibility into sustainable mid-...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.